Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Pain Management Market Research Reports

Titlepublishedprice

Global Opioids Sales Market Report 2016

By QYResearch Group
"...... s, price, revenue and market share for each player in these regions, covering - Sanofi-aventis - Johnson & Johnson - Teva pharmaceuticals - Purdue Pharma - Pfizer - Orexo Pharmaceuticals - Endo Pharmac......"
29-Nov-2016$4000

Global Tramadol Market Research Report 2016

By QYResearch Group
"...... duction, price, revenue and market share for each manufacturer, covering - Grnenthal GmbH - Mundipharma - Hexal AG - Labopharm - Pliva Pharma - Nippon Shinyaku - Atoz Pharmaceuticals - Rompharm ......"
25-Nov-2016$2900

Musculoskeletal Pain-Pipeline Insights, 2016

By Delve Insight
"...... linical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA des......"
01-Nov-2016$1250

Myalgia-Pipeline Insights, 2016

By Delve Insight
"...... se II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveIn......"
01-Nov-2016$1250

Non Malignant pain-Pipeline Insights, 2016

By Delve Insight
"...... cal, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designa......"
01-Nov-2016$1250

Acute Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... derstand the market and pipeline status of the drugs around the Acute Pain to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provide......"
01-Nov-2016$2000

Fibromyalgia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... o understand the market and pipeline status of the drugs around the Fibromyalgia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report p......"
01-Nov-2016$2000

Acute Pain-API Insights, 2016

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Nov-2016$1250

Fibromyalgia-Pipeline Insights, 2016

By Delve Insight
"...... ase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations detail......"
01-Nov-2016$1250

Chronic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... o understand the market and pipeline status of the drugs around the Chronic Pain to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report p......"
01-Nov-2016$2000

Avail upto 50% Discount on below Publisher Reports.